Press Resease

Heart Valve Devices Market by Procedure (Heart Valve Replacement Devices (Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other), Heart valve Repair Devices (Surgical Valve, Balloon Valvuloplasty Devices, TMVR)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016- 2022

Published Date: 12-Dec-2017 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-2511 Status : Published

Global heart valve devices market is expected to reach USD 10.35 billion by 2022, growing at a CAGR of 13% between 2017 and 2022.

Description

The report covers forecast and analysis for the Heart Valve Devices Market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the heart valve devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the heart valve devices market on a global level.

In order to give the users of this report a comprehensive view of the heart valve devices market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, where procedure, end user, and regional segmentation are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new procedure launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis.

The study provides a decisive view of the heart valve devices market by segmenting the market based on procedure, end user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2022.

Based on the procedure, Heart Valve Devices Market is segmented as heart valve replacement devices and heart valve repair devices. Heart valve replacement devices are further sub-segmented on the basis of techniques as a mechanical valve, Bioprosthetic valve and TAVR (Transcatheter Aortic Valve Replacement). Heart valve replacement devices are further sub-segmented on the basis of the position where they are replaced as mitral valve replacement devices, aortic valve replacement devices, and other position heart valve replacement devices. Heart valve repair devices are further sub-segmented on the basis of techniques as surgical valve repair devices, balloon valvuloplasty devices and TMVR (Transcatheter Mitral Valve Repair). Based on end-user heart valve devices market is segmented as hospitals and ambulatory surgical centers.

Increasing sedentary lifestyle triggering the rate of obesity, growing various cardiac diseases and pathological disorders are the major driving factors of Heart Valve Devices Market. Whereas, complex regulatory procedures and   high prices of devices and procedures are additional factors that influence the market growth during the forecast period.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Mexico, Germany, Spain, Italy, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for Heart Valve Devices Market based on individual segment and applications in all the regions and countries.

The report also includes detailed profiles of end players such as Abbott, Medtronic, CryoLife, Inc., Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, JenaValve Technology, Inc., and Lepu Medical Technology Co., Ltd. among others.

This report segments the global Heart Valve Devices Market as follows:

Global Heart Valve Devices Market: by Procedure

  • Heart Valve Replacement Devices
  • By technique:
    • Mechanical Valve
    • Bioprosthetic Valve
    • TAVR (Transcatheter Aortic Valve Replacement)
  • By Position:
    •  Mitral Valve Replacement Devices
    • Aortic Valve Replacement Devices
    • Other Position Heart Valve Replacement Devices
  • Heart Valve Repair Devices
    • Surgical Valve Repair Devices
    • Balloon Valvuloplasty Devices
    • TMVR (Transcatheter Mitral Valve Repair)

Global Heart Valve Devices Market: by End User

  • Hospital
  • Ambulatory Surgical Centers

Global Heart Valve Devices Market: by Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Heart Valve Devices Market, 2014 – 2022 (USD Billion)
    • 2.2. Global Heart Valve Devices Market: Snapshot
  • Chapter 3. Heart Valve Devices Market Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Heart Valve Devices Market drivers: Impact analysis
      • 3.2.2. Escalating sedentary life triggering the rate of obesity
      • 3.2.3. Growing various cardiac diseases and pathological disorders
    • 3.3. Market restraints
      • 3.3.1. Complex regulatory procedures
      • 3.3.2. High device and procedure cost
    • 3.4. Opportunities
      • 3.4.1. Rising awareness among the patients
    • 3.5. Porter’s five forces analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Procedure
      • 3.6.2. Market attractiveness analysis, by End user
      • 3.6.3. Market attractiveness analysis, by Regional Segment
  • Chapter 4. Global Heart Valve Devices Market – Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Heart Valve Devices Market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Procedure Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  • Chapter 5. Global Heart Valve Devices Market – Procedure Segment Analysis
    • 5.1. Global Heart Valve Devices Market: Procedure overview
      • 5.1.1. Global Heart Valve Devices Market revenue share, by Procedure, 2014 and 2022(USD Billion)
    • 5.2. Heart Valve Replacement Devices
      • 5.2.1. Global Heart Valve Replacement Devices Market, 2014 – 2022(USD Billion)
    • 5.3. Heart Valve Repair Devices
      • 5.3.1. Global Heart Valve Repair Devices Market, 2014 – 2022(USD Billion)
  • Chapter 6. Global Heart Valve Devices Market – End user Segment Analysis
    • 6.1. Global Heart Valve Devices Market: End user overview
      • 6.1.1. Global Heart Valve Devices Market revenue share, by End user, 2014 and 2022(USD Billion)
    • 6.2. Hospital
      • 6.2.1. Global Heart Valve Devices Market for Hospital, 2014 – 2022(USD Billion)
    • 6.3. Ambulatory Surgical Centers
      • 6.3.1. Global Heart Valve Devices Market for Ambulatory Surgical Centers, 2014 – 2022(USD Billion)
  • Chapter 7. Global Heart Valve Devices Market – Regional Segment Analysis
    • 7.1. Global Heart Valve Devices Market: Regional overview
      • 7.1.1. Global Heart Valve Devices Market revenue share, by Region, 2015 and 2021
    • 7.2. North America
      • 7.2.1. North America Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
      • 7.2.2. North America Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
      • 7.2.3. North America Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.2.4. U.S.
        • 7.2.4.1. U.S. Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.2.4.2. U.S. Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.2.4.3. U.S. Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.2.5. Canada
        • 7.2.5.1. Canada Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.2.5.2. Canada Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.2.5.3. Canada Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
      • 7.3.2. Europe Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
      • 7.3.3. Europe Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.3.4.2. Germany Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.3.4.3. Germany Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.3.5. U.K.
        • 7.3.5.1. U.K. Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.3.5.2. U.K. Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.3.5.3. U.K. Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.3.6. France
        • 7.3.6.1. France Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.3.6.2. France Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.3.6.3. France Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.3.7. Italy
        • 7.3.7.1. Italy Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.3.7.2. Italy Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.3.7.3. Italy Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.3.8. Spain
        • 7.3.8.1. Spain Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.3.8.2. Spain Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.3.8.3. Spain Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.3.9. Russia
        • 7.3.9.1. Russia Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.3.9.2. Russia Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.3.9.3. Russia Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.3.10.2. Rest of Europe Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.3.10.3. Rest of Europe Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
      • 7.4.2. Asia Pacific Heart Valve Devices Market revenue, End user, 2014 – 2022(USD Billion)
      • 7.4.3. Asia Pacific Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.4.4. China
        • 7.4.4.1. China Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.4.4.2. China Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.4.4.3. China Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.4.5. Japan
        • 7.4.5.1. Japan Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.4.5.2. Japan Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.4.5.3. Japan Heart Valve Devices Market revenue, by region, 2014 – 2022(USD Billion)
      • 7.4.6. India
        • 7.4.6.1. India Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.4.6.2. India Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.4.6.3. India Heart Valve Devices Market revenue, by region, 2014 – 2022(USD Billion)
      • 7.4.7. Australia
        • 7.4.7.1. Australia Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.4.7.2. Australia Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.4.7.3. Australia Heart Valve Devices Market revenue, by region, 2014 – 2022(USD Billion)
      • 7.4.8. Rest of Asia Pacific
        • 7.4.8.1. Rest of Asia Pacific Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.4.8.2. Rest of Asia Pacific Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.4.8.3. Rest of Asia Pacific Heart Valve Devices Market revenue, by region, 2014 – 2022(USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
      • 7.5.2. Latin America Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
      • 7.5.3. Latin America Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.5.4. Mexico
        • 7.5.4.1. Mexico Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.5.4.2. Mexico Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.5.4.3. Mexico Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.5.5.2. Brazil Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.5.5.3. Brazil Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.5.6.2. Argentina Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.5.6.3. Argentina Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.5.7.2. Rest of Latin America Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.5.7.3. Rest of Latin America Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
    • 7.6. Middle East and Africa
      • 7.6.1. Middle East and Africa Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
      • 7.6.2. Middle East and Africa Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
      • 7.6.3. Middle East and Africa Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.6.4. Saudi Arabia
        • 7.6.4.1. Saudi Arabia Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.6.4.2. Saudi Arabia Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.6.4.3. Saudi Arabia Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.6.5. UAE
        • 7.6.5.1. UAE Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.6.5.2. UAE Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.6.5.3. UAE Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.6.6.2. South Africa Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.6.6.3. South Africa Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.6.7. Qatar
        • 7.6.7.1. Qatar Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.6.7.2. Qatar Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
      • 7.6.8. Qatar Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
      • 7.6.9. Rest of Middle East and Africa
        • 7.6.9.1. Rest of Middle East and Africa Heart Valve Devices Market revenue, by Procedure, 2014 – 2022(USD Billion)
        • 7.6.9.2. Rest of Middle East and Africa Heart Valve Devices Market revenue, by End user, 2014 – 2022(USD Billion)
        • 7.6.9.3. Rest of Middle East and Africa Heart Valve Devices Market revenue, by Region, 2014 – 2022(USD Billion)
  • Chapter 8. Company Profile
    • 8.1. Abbott
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. CryoLife, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. Boston Scientific Corporation
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Edward Lifesciences Corporation
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. TTK HealthCare
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. JenaValve Technology, Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Medtronic
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Neovasc, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Sorin Group
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Therapy portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. Micro Interventional Devices, Inc.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Therapy portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments
    • 8.11. Lepu Medical Technology Co., Ltd.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Therapy portfolio
      • 8.11.4. Business strategy
      • 8.11.5. Recent developments

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Heart Valve Devices market. Zion Research has collected and analyzed key data belong to the global Heart Valve Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined after conducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Heart Valve Devices across the world has been calculated through primary and secondary research.

Zion Research employs the combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assisted in validation of findings from secondary research and to understand key trends in the Heart Valve Devices industry. Primary research makes up the major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening the secondary research findings
  • Further, develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

  • Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
  • Purchasing managers, technical personnel, distributors and resellers
  • Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

  • Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
  • IDC and other relevant magazines
  • Internal and external proprietary databases, and relevant patent and regulatory databases
  • National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Heart Valve Devices market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

  • Demographic data: Population split by segments
  • Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
  • Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
  • Data is then cross-checked by an expert panel.

Free Analysis

In mammals, four heart valves are there (mitral valve, tricuspid valve, aortic valve, and pulmonary valve) which responsible for keep blood flow in right direction. Sometimes, one or more of the valves don't open or close properly. This results in the blood flow through your heart to your body to be disrupted. It’s called as heart valve disease, and treatment of heart valve disease depends on the heart valve affected and the type and severity of the valve disease. Heart valve disease may require surgery to repair or replace the heart valve. Regurgitation, stenosis, and atresia are basic problems related to the heart valve. Heart valve disease can be present at birth, or it can also occur in adults due to many causes and conditions, such as infections and other heart conditions. Factors which can increase the risk of heart valve disease are older age, history of certain infections that can affect the heart, certain forms of heart disease or heart attack, high blood pressure, high cholesterol, diabetes and other heart disease risk factors, and heart conditions present at birth (congenital heart disease).

Increasing sedentary lifestyle triggering the rate of obesity and growing various cardiac diseases and pathological disorders are some of the major drivers of Heart Valve Devices Market. According to Heart Valve Society of America, more than 5 million Americans are suffering from heart valve disease. Many people left undiagnosed and untreated, as their condition can cause a progressive deterioration in heart function, which can result in heart failure and premature death. Symptoms of heart valve diseases are shortness of breath and/or difficulty catching your breath, discomfort in your chest, weakness, irregular heartbeat, swelling of your ankles, feet or abdomen and rapid weight gain. This symptom may occur or may not in some people; it slowly develops and worsens over time which may cause the death of a person. However, complex regulatory procedures and the high price of devices and procedure may hamper the growth of the heart valve devices market. However, growth in transcatheter heart valves and demand for heart valve devices in the Asia Pacific region may create a significant opportunity for heart valve devices market in the coming years.

Global-Heart-Valve-Devices-Market.png

The Heart Valve Devices Market is classified based on procedure, end-user, and region. On the basis of procedure, the market is divided into heart valve replacement devices and heart valve repair devices. Heart valve replacement devices are further sub-segmented on the basis of techniques as a mechanical valve, Bioprosthetic valve and TAVR (Transcatheter Aortic Valve Replacement). Heart valve replacement devices are further sub-segmented on the basis of the position where they are replaced as mitral valve replacement devices, aortic valve replacement devices, and other position heart valve replacement devices. Heart valve repair devices are further sub-segmented on the basis of techniques as surgical valve repair devices, balloon valvuloplasty devices and TMVR (Transcatheter Mitral Valve Repair). Due to the escalating use of technologically superior products, more than average selling prices, and considerably lower mortality rate achieved by the devices, the transcatheter heart valve devices accounts for maximum share in the market. On the basis of the end-user market is divided into hospitals and ambulatory surgical centers.

By geography, North America dominates the Heart Valve Devices Market owing rising usage of technologically superior products in this region. Other major driving factors in the North America region is increasing rate of obesity and prevalence of cardiac diseases in this region. Additionally, the presence of major market players, such as Boston Scientific Corporation, Abbott, and Medtronic, in the U.S. is anticipated to contribute significantly to the revenue generation of the country. Europe is also a major market for heart valve devices market due to supportive policies of the government, number of product launches, and a large pool of elderly highly susceptible to various heart diseases.

In Asia Pacific region due to the high prevalence of heart valve diseases and developing healthcare, infrastructure creates significant opportunity in the near future. The Middle East and Africa are anticipated to witness significant growth during the forecast period.

Some of the key players in Heart Valve Devices Market include Abbott, Medtronic, CryoLife, Inc., Boston Scientific Corporation, Micro Interventional Devices, Inc., Neovasc, Inc., Edward Lifesciences Corporation, Sorin Group, TTK HealthCare, JenaValve Technology, Inc., and Lepu Medical Technology Co., Ltd. among others.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com